Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2012
10/31/2012CN101711236B N-oxide and/or di-N-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
10/31/2012CN101679317B Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor binding activity
10/31/2012CN101675032B Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
10/31/2012CN101573130B Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy
10/31/2012CN101538311B Alpha-amido acyl-ring imide peptoid metalloprotease inhibitor and application thereof
10/31/2012CN101454297B Aryl-4-ethynyl-isoxazole derivatives
10/31/2012CN101395138B Sigma receptor inhibitors
10/31/2012CN101287712B Heterocyclic compounds
10/31/2012CN101049290B Application of agomelatine in preparing medicine for treating generalized anxiety disorder
10/30/2012US8299120 Therapy for multiple sclerosis
10/30/2012US8299064 Fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof
10/30/2012US8298580 Sustained-release formulations of topiramate
10/30/2012US8298525 Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist
10/30/2012CA2602950C Methods for the treatment of central nervous system injury via a tapered administration of progesterone
10/30/2012CA2568592C Alkyl substituted indoloquinoxalines
10/30/2012CA2567484C Pyrimidine compounds and their use as modulators of the dopamine d3 receptor
10/30/2012CA2566896C Bicyclic-substituted amines having cyclic-substituted monocyclic substituents for modulating effects of histamine-3 receptor
10/30/2012CA2566297C Substituted cyclohexyl-1,4-diamine derivatives
10/30/2012CA2565293C Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
10/30/2012CA2534664C Modafinil compositions
10/30/2012CA2512639C Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
10/30/2012CA2474874C Anticholinergic agents, method for producing the same and use thereof as medicaments
10/30/2012CA2411374C Dual specificity antibodies and methods of making and using
10/26/2012WO2012145746A1 Compositions and methods for the treatment of neuromyelitis optica
10/26/2012WO2012145737A1 Fatty acid amide hydrolase inhibitors for treating
10/26/2012WO2012145651A2 Compounds for the treatment of neuropsychiatric disorders
10/26/2012WO2012145581A1 Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
10/26/2012WO2012145428A2 Altering protein concentrations in cerebrospinal fluid and/or brain interstitial fluid
10/26/2012WO2012145234A2 Cyclopropyl derivatives and methods of use
10/26/2012WO2012145098A1 Use of adenosine a3 receptor agonists for treatment of neuropathic pain
10/26/2012WO2012144972A2 Methods to inhibit neurodegeneration
10/26/2012WO2012144854A2 Novel uses of licochalcone a
10/26/2012WO2012144661A1 Aromatic heterocyclic derivative having trpv4-inhibiting activity
10/26/2012WO2012144613A1 Method for producing complex crystal and method for screening complex crystal
10/26/2012WO2012144478A1 Tetrahydrothiazepine derivative
10/26/2012WO2012143924A1 Random pentapolymer for treatment of autoimmune diseases
10/26/2012WO2012143860A1 Ameliorating cognitive decline
10/26/2012WO2012143703A1 Dibenzothiazepine derivatives and their use in the treatment of cns disorders
10/26/2012WO2012143526A1 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
10/26/2012WO2012143340A1 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/ 2-pyrimidine-carborxamides as mglur5 modulators
10/26/2012WO2012143337A1 Novel modulators of cortical dopaminergic- and nmda-receptor-mediated glutamatergic neurotransmission
10/26/2012WO2012143143A1 Heterocyclic compounds as kinase inhibitors
10/26/2012WO2012143117A1 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives
10/26/2012WO2012143116A1 4-oxo-1-imidazolidinyl imidazothiadiazole derivatives
10/26/2012WO2012142666A1 Method of modulating amine oxidase activity and agents useful for same
10/26/2012WO2012117076A3 Baclofen and acamprosate based therapy of neurogical disorders
10/26/2012WO2012115439A9 Composition comprising expression or activity regulators of akap12 for treating central nerve system diseases
10/26/2012WO2012110636A3 Carrier peptides for cell delivery
10/26/2012WO2012104550A3 INHIBITORS OF THE INTERACTION OF THE SIGMA-1 RECEPTOR WITH hERG FOR USE IN THE TREATMENT OF CANCER
10/26/2012WO2012092160A3 Neutral human milk oligosaccharides to promote growth of beneficial bacteria
10/26/2012WO2012088038A3 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
10/26/2012WO2012082942A3 Neuropeptide analogs, compositions, and methods for treating pain
10/26/2012WO2012082903A3 Treatment of cognitive impairment in a subject with a neurological autoimmune disease
10/26/2012WO2012080727A4 Casein kinase 1delta (ck1delta) inhibitors
10/26/2012WO2012075242A3 Controlled chemical release of hydrogen sulfide
10/26/2012WO2011146876A3 Oral transmucosal administration of sufentanil
10/26/2012CA2837134A1 Compounds for the treatment of neuropsychiatric disorders
10/26/2012CA2833961A1 Fatty acid amide hydrolase inhibitors for treating pain
10/26/2012CA2833648A1 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
10/26/2012CA2833320A1 Dibenzothiazepine derivatives and their use in the treatment of cns disorders
10/26/2012CA2832874A1 Novel modulators of cortical dopaminergic- and nmda-receptor-mediated glutamatergic neurotransmission
10/26/2012CA2831830A1 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives
10/26/2012CA2831680A1 Heterocyclic compounds as kinase inhibitors
10/26/2012CA2825971A1 5-(phenyl/pyridinyl-ethinyl) -2 -pyridine/ 2 -pyrimidine-carborxamides as mglur5 modulators
10/25/2012US20120270948 Polymorphisims in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications
10/25/2012US20120270932 Personal Care Compositions with Improved Hyposensitivity
10/25/2012US20120270924 Oligomeric Compounds For The Modultion of HIF-1A Expression
10/25/2012US20120270916 Topical formulations for treating neuropathy
10/25/2012US20120270915 Fatty acid amide hydrolase inhihibitors for treating pain
10/25/2012US20120270912 Substituted Indolealkanoic Acids
10/25/2012US20120270903 Intranasal spray device containing pharmaceutical composition
10/25/2012US20120270902 N-substituted benzene sulfonamides
10/25/2012US20120270897 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
10/25/2012US20120270895 Intranasal Opioid Compositions
10/25/2012US20120270894 Controlled Release of Phenolic Opioids
10/25/2012US20120270892 Aminopyrimidine Kinase Inhibitors
10/25/2012US20120270883 Use of a polymorph of flibanserin for treating disease
10/25/2012US20120270881 Conformationally constrained, fully synthetic macrocyclic compounds
10/25/2012US20120270879 Heterocyclic Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270876 Treatment of Conditions Through Pharmacological Modulation of the Autonomic Nervous System
10/25/2012US20120270874 Biaryl Compositions and Methods for Modulating a Kinase Cascade
10/25/2012US20120270873 Adamantyl diamide derivatives and uses of same
10/25/2012US20120270870 Indazole and Pyrazolopyridine Compounds As CCR1 Receptor Antagonists
10/25/2012US20120270868 Rho kinase inhibitors
10/25/2012US20120270866 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
10/25/2012US20120270862 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/25/2012US20120270861 Primary Amines And Derivatives Thereof As Modulators Of The 5-HT2A Serotonin Receptor Useful For The Treatment Of Disorders Related Thereto
10/25/2012US20120270860 Methods for treating or preventing alcohol-related disorders or craving-related disorders
10/25/2012US20120270857 5-ht3 receptor modulators, methods of making, and use thereof
10/25/2012US20120270855 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
10/25/2012US20120270852 Phenyl or pyridinyl-ethynyl derivatives
10/25/2012US20120270850 Metal delivery agents and therapeutic uses of the same
10/25/2012US20120270848 Novel Compositions and Therapeutic Methods Using Same
10/25/2012US20120270847 Novel carbamate amino acid and peptide prodrugs of opiates and uses thereof
10/25/2012US20120270846 Preparation of an acetyl salicylic acid/glutamic acid complex for oral administration
10/25/2012US20120270845 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
10/25/2012US20120270844 Methods for treating alzheimer's disease
10/25/2012US20120270836 Therapeutic approaches for treating alzheimer's disease
10/25/2012US20120270829 Use of adenosine a3 receptor agonists for treatment of neuropathic pain
10/25/2012US20120270823 Aureolic acid derivatives, the method for preparation thereof and the uses thereof
1 ... 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 ... 1833